Rectal cancer radiotherapy: Towards European consensus

References

• Valentini V, Beets-Tan R, Borras JM, Krivokapicć Z, Leer JW, Påhlman L, . Evidence and research in rectal cancer. Radiother Oncol 2008;87:449–74.
   PubMed Web of Science ®Google Scholar
• Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, . Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 2009;92:148–63.
   PubMed Web of Science ®Google Scholar
• Valentini V, Glimelius B, Minsky BD, Van Cutsem E, Bartelink H, Beets-Tan RG, . The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol 2005;76:241–50.
   PubMed Web of Science ®Google Scholar
• Rowe G, Wright G. The Delphi technique as a forecasting tool: Issues and analysis. Int J Forecast 1999;4:353–75.
   Google Scholar
• Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging: A meta-analysis. Radiology 2004;232:773–83.
   PubMed Web of Science ®Google Scholar
• Marusch F, Koch A, Schmidt U, Zippel R, Kuhn R, Wolff S, . Routine use of transrectal ultrasound in rectal carcinoma: Results of a prospective multicenter study. Endoscopy 2002;34:385–90.
   PubMed Web of Science ®Google Scholar
• Ptok H, Marusch F, Meyer F, Wendling P, Wenisch HJ, Sendt W, . Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice. Eur J Surg Oncol 2006;32:420–5.
   PubMed Web of Science ®Google Scholar
• Nesbakken A, Løvig T, Lunde OC, Nygaard K. Staging of rectal carcinoma with transrectal ultrasonography. Scand J Surg 2003;92:125–9.
   PubMedGoogle Scholar
• Schnall MD, Furth EE, Rosato EF, Kressel HY. Rectal tumor stage: Correlation of endorectal MR imaging and pathologic findings.Radiology 1994;190:709–14.
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim SH, Choi D, Kim MJ, Chun HK, Lee SJ, . Comparison between 3-T magnetic resonance imaging and multi-detector row computed tomography for the preoperative evaluation of rectal cancer. J Comput Assist Tomogr 2007;31:853–9.
   PubMed Web of Science ®Google Scholar
• Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, . Rectal carcinoma: Thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215–22.
   PubMed Web of Science ®Google Scholar
• Vliegen R, Dresen R, Beets G, Daniels-Gooszen A, Kessels A, van Engelshoven J, . The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer. Abdom Imaging 2008;33: 604–10.
   PubMedGoogle Scholar
• Kulinna C, Scheidler J, Strauss T, Bonel H, Herrmann K, Aust D, . Local staging of rectal cancer: Assessment with double-contrast multislice computed tomography and transrectal ultrasound. J Comput Assist Tomogr 2004;28: 123–30.
   PubMed Web of Science ®Google Scholar
• Wolberink SV, Beets-Tan RG, de Haas-Kock DF, Span MM, van de Jagt EJ, van de Velde CJ, . Conventional CT for the prediction of an involved circumferential resection margin in primary rectal cancer. Dig Dis 2007;25:80–5.
   PubMed Web of Science ®Google Scholar
• MERCURY Study group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY Study. Radiology 2007;243:132–9.
   PubMed Web of Science ®Google Scholar
• Lahaye MJ, Engelen SM, Nelemans PJ, Beets GL, van de Velde CJ, van Engelshoven JM, . Imaging for predicting the risk factors–the circumferential resection margin and nodal disease–of local recurrence in rectal cancer: A meta-analysis. Semin Ultrasound CT MR 2005;26:259–68.
   PubMed Web of Science ®Google Scholar
• Gearhart SL, Frassica D, Rosen, Choti M, Schulick R, Wahl R. Improved staging with pretreatment positron emission tomography/computed. Ann Surg Oncol 2006;13:397–404.
   PubMed Web of Science ®Google Scholar
• Vliegen RF, Beets-Tan RG, Vanhauten B, Driessen A, Oellers M, Kessels AG, . Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 2008;184:457–64.
   PubMed Web of Science ®Google Scholar
• Smith N, Brown G. Preoperative staging of rectal cancer. Acta Oncol 2008;47:20–31.
   PubMed Web of Science ®Google Scholar
• Pomerri F, Maretto I, Pucciarelli S, Rugge M, Burzi S, Zandonà M, . Prediction of rectal lymph node metastasis by pelvic computed tomography. Eur J Surg Oncol 2009;35: 168–73.
   PubMed Web of Science ®Google Scholar
• Koh DM, Chau I, Tait D, Wotherspoon A, Cunningham D, Brown G. Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2008;71:456–61.
   PubMed Web of Science ®Google Scholar
• Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, . Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009;250:730–9.
   PubMed Web of Science ®Google Scholar
• Calvo FA, Domper M, Matute R, Martínez-Lázaro R, Arranz JA, Desco M, . 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 2004;58:528–35.
   PubMed Web of Science ®Google Scholar
• Stamos MJ, Murrell Z. Management of early rectal T1 and T2 cancers. Clin Cancer Res 2007;13:6885–9.
   Web of Science ®Google Scholar
• Baatrup G, Endreseth BH, Isaksen V, Kjellmo A, Tveit KM, Nesbakken A. Preoperative staging and treatment options in T1 rectal adenocarcinoma. Acta Oncol 2009;48:328–42.
   PubMed Web of Science ®Google Scholar
• Doornebosch PG, Tollenaar RA, De Graaf EJ. Is the increasing role of Transanal Endoscopic Microsurgery in curation for T1 rectal cancer justified? A systematic review. Acta Oncol 2009;48:343–53.
   PubMed Web of Science ®Google Scholar
• Willett, CG. Sphincter preservation in rectal cancer. Local excision followed by postoperative radiation therapy. Semin Radiat Oncol 1998;8:24–9.
   PubMed Web of Science ®Google Scholar
• Wagman RT, Minsky BD. Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Huntingt) 2001;15:513–9.
   PubMed Web of Science ®Google Scholar
• Gérard JP, Ortholan C, Benezery K, Ginot A, Hannoun-Levi JM, Chamorey E, . Contact x-ray therapy for rectal cancer: Experience in Centre Antoine-Lacassagne, Nice, 2002–2006. Int J Radiat Oncol Biol Phys 2008;72:665–70.
   PubMed Web of Science ®Google Scholar
• Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, . Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009;373:811–20.
   PubMed Web of Science ®Google Scholar
• Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, . Dutch Colorectal Cancer Group The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693–701.
   PubMed Web of Science ®Google Scholar
• Guerrieri M, Baldarelli M, Organetti L, Grillo Ruggeri F, Mantello G, Bartolacci S, . Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc 2008;22: 2030–5.
   PubMed Web of Science ®Google Scholar
• Radu C, Berglund K, Påhlman L, Glimelius B. Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study. Radiother Oncol 2008;87: 343–9.
   PubMed Web of Science ®Google Scholar
• Hatfield P, Hingorani M, Radhakrishna G, . Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 2009;92:210–4.
   PubMed Web of Science ®Google Scholar
• Camma C, Giunta M, Fiorica F, Pagliaro L, Craxì A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A metaanalysis. JAMA 2000;284:1008–15.
   PubMed Web of Science ®Google Scholar
• Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358:1291–304.
   PubMed Web of Science ®Google Scholar
• Munro AJ, Bentley A. Adjuvant radiotherapy in operable rectal cancer: A systematic review. Sem Colon Rectal Surg 2002; 13:31–42.
   Google Scholar
• Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;42:476–92.
   PubMed Web of Science ®Google Scholar
• Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, . The Swedish rectal cancer registry. Br J Surg 2007;94:1285–92.
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, . EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006;355:1114–23.
   PubMed Web of Science ®Google Scholar
• Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT, . Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006;24: 4620–5.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–23.
   PubMed Web of Science ®Google Scholar
• Ngan S, Fisher R, Godstein D, Solomon M, Burmeister B, Ackland SP, . A randomized trial comparing local recurrence (LR) rates between short-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol 2010 (Suppl abstr 3509);28:7s.
   Web of Science ®Google Scholar
• Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, . Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004;47:1798–807.
   PubMed Web of Science ®Google Scholar
• Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, . Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99–107.
   PubMed Web of Science ®Google Scholar
• Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, . The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752–60.
   PubMed Web of Science ®Google Scholar
• Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, . Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010;28:1638–44.
   PubMed Web of Science ®Google Scholar
• Aschele C, Pinto C, Cordio S, Rosati G, Tagliagambe A, Artale S, . Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. ASCO J Clin Oncol 2009(Suppl; abstr CRA4008);27:18s.
   Web of Science ®Google Scholar
• Guillem JG, Díaz-González JA, Minsky BD, Valentini V, Jeong SY, Rodriguez-Bigas MA, . cT3N0 rectal cancer: Potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 2008;26:368–73.
   PubMed Web of Science ®Google Scholar
• Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP; Lyons Oncology Group. Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003;90:996–8.
   PubMed Web of Science ®Google Scholar
• Wong RK, Tandan V, De Silva S, Figueredo A.Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev(2): CD002102.
   Google Scholar
• Bujko K, Kepka L, Michalski W, Nowacki MP. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 2006; 80:4–12.
   PubMed Web of Science ®Google Scholar
• Påhlman L. Optimal management of rectal cancer – Is sphincter saving an important end-point? EJC Suppl 2005;65: 365–9.
   Google Scholar
• Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maingon P, . Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 2007;25:4379–86.
   PubMed Web of Science ®Google Scholar
• QUASAR Collaborative Group: Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 2007;370:2020–9.
   PubMed Web of Science ®Google Scholar
• Bosset JF, Horiot JC, Hamers HP, Cionini L, Bartelink H, Caspers R, . Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 2001;61:7–13.
   PubMed Web of Science ®Google Scholar
• NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–50.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, . For the German Rectal Cancer Study Group. Pre-operative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med 2004;351:1731–40.
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, . Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: A pooled analysis. Int J Radiat Oncol Biol Phys 2002;54: 386–96.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee JH, Ahn JH, Bahng H, Kim TW, Kang YK, . Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report. J Clin Oncol 2002;20:1751–8.
   PubMed Web of Science ®Google Scholar
• Fountzilas G, Zisiadis A, Dafni U, Konstantaras C, Hatzitheoharis G, Liaros A, . Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: A randomized phase. Ann Oncol 1999;10:671–6.
   PubMed Web of Science ®Google Scholar
• Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, . Randomized controlled trial of postoperative radiotherapy and short-term timescheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal C. Br J Surg 1997; 84:1130–5.
   PubMed Web of Science ®Google Scholar
• Pahlman L, Glimelius B. Pre-or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg 1990;211:187–95.
   PubMed Web of Science ®Google Scholar
• Braendengen M, Tveit KM, Berglund A, Birkemeyer E, Frykholm G, Påhlman L, . Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008;26: 3687–94.
   PubMed Web of Science ®Google Scholar
• Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, . A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma. Int J Radiat Oncol Biol Phys 2001;50: 1299–308.
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Winter K, Mitchell E, Hanna N, Yuen A, Nichols C, . Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006;24:650–5.
   PubMed Web of Science ®Google Scholar
• De Ridder M, Tournel K, Van Nieuwenhove Y, Engels B, Hoorens A, Everaert H, . Phase II study of preoperative helical tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:728–34.
   PubMed Web of Science ®Google Scholar
• Janjan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, . Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2000;47:713–8.
   PubMed Web of Science ®Google Scholar
• Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R, . Locally advanced primary colorectal cancer: Intraoperative electron and external beam irradiation +/-5-FU. Int J Radiat Oncol Biol Phys 1997;37:601–14.
   PubMed Web of Science ®Google Scholar
• Mannaerts GH, Rutten HJ, Martijn H, Hanssens PE, Wiggers T. Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 2001;44:1749–58.
   PubMed Web of Science ®Google Scholar
• Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002;62: 207–13.
   PubMed Web of Science ®Google Scholar
• Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radio(chemo)therapy? A systematic review of randomized trials. Ann Oncol 2010;doi: 10.1093/annonc/mdq054.
   Google Scholar
• Glimelius B. Adjuvant chemotherapy in rectal cancer – an issue or a non-issue? Ann Oncol 2010;doi: 10.1093/annonc/mdq263.
   Google Scholar
• Glimelius B. Rectal cancer irradiation. Long course, short course or something else? Acta Oncol 2006;45:1013–7.
   PubMed Web of Science ®Google Scholar
• Pettersson D, Cedermark B, Holm T, Radu C, Påhlman L, Glimelius B, . Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens in rectal cancer. Br J Surg 2010;97:580–7.
   PubMed Web of Science ®Google Scholar
• Gunnlaugsson A, Anderson H, Fernebro E, Kjellén E, Byström P, Berglund K, . Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L Study. Eur J Cancer 2009;45:807–13.
   PubMed Web of Science ®Google Scholar
• Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A, . Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: A phase 2 trial. Lancet Oncol 2010;11:241–8.
   PubMed Web of Science ®Google Scholar
• Rodel C, Arnold D, Hipp M, Liersch T, Dellas K, Iesalnieks I, . Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys 2008;70:1081–6.
   PubMed Web of Science ®Google Scholar
• Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Ströbel P, . Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a Phase II MARGIT trial. Int J Radiat Oncol Biol Phys 2009;74:1487–93.
   PubMed Web of Science ®Google Scholar
• Bertolini F, Chiara S, Bengala C, Antognoni P, Dealis C, Zironi S, . Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: A phase II study in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2009;73:466–72.
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Mawdsley S, Harrison M. Cetuximab and chemoradiation for rectal cancer-is the water getting muddy? Acta Oncol 2010;49:278–86.
   PubMed Web of Science ®Google Scholar
• Willett CG, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Sahani DV, . Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: A multidisciplinary phase II study. J Clin Oncol 2009;27:3020–6.
   PubMed Web of Science ®Google Scholar
• Crane CH, Eng C, Feig BW, Das P, Skibber JM, Chang GJ, . Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2010;76:824–30.
   PubMed Web of Science ®Google Scholar
• Ippolito E, Mertens I, Haustermans K, Gambacorta MA, Pasini D, Valentini V. IGRT in rectal cancer. Acta Oncol 2008;47:1317–24.
   PubMed Web of Science ®Google Scholar